Regen Biologics Inc.

One of the largest gatherings of orthopedic surgeons specializing in arthroscopy and sports medicine, the Third Annual Emerging Techniques in Orthopedics: Arthroscopy and Sports Medicine (ETO) meeti

Shuren Touts Premarket Benefits Of Planned National Postmarket Strategy The device center within the US Food and Drug Administration (FDA) plans to propose a new national comprehensive postmarket surv

Late in the day on June 29, 2011, the Centers for Medicare & Medicaid Services was swamped with reporters’ questions. FDA’s Oncologic Drugs Advisory Committee had just unanimously voted to withdraw A

Start-ups and investors are looking to address the large and growing gap between palliative treatment and major joint surgery for patients with cartilage damage in the knee, toes and hands – although